Evolution of the Average Target: Vertex, Inc.

Evolution of the Target Price: Vertex, Inc.

Changes in Analyst Recommendations: Vertex, Inc.

44f065e3b3f8d4fe5c3.UuivS05_w9Puh_bCNroMlOcVqna8TbOWQSkaPlMytyg.ZY3aJhk7laOL0ZOHVeB_4JU49QTxeIPyBmN_VSR5xxs13eV8HTGbstfPnQ~041908acb44bd1146101090a2f5183bb
07-21 Vertex Facing Uncertain Growth Path Amid AI Fears, Morgan Stanley Says MT
07-21 Morgan Stanley Downgrades Vertex to Equalweight From Overweight Adjusts PT to $15 From $19 MT
07-21 Morgan Stanley Downgrades Vertex to Equalweight From Overweight, Cuts Price Target to $15 From $19 MT
07-21 Analyst recommendations: Gilead, Salesforce, Goldman Sachs, Carvana, Crowdstrike… Zonebourse
06-29 TD Cowen Initiates Vertex at Buy With $14 Price Target MT
02-12 Vertex Shares Fall After Jefferies Downgrade MT
02-12 Jefferies Downgrades Vertex to Hold From Buy, Adjusts Price Target to $16 From $28 MT
02-12 Morgan Stanley Cuts Price Target on Vertex to $20 From $33, Keeps Overweight Rating MT
02-12 Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap… Zonebourse
02-03 Piper Sandler Downgrades Vertex to Neutral From Overweight MT
11-03 (VERX) Vertex Expects 2025 Revenue Range $745.7M to $749.7M, vs. FactSet Est of $752.3M MT
21/10/25 Vertex, Inc. Announces Executive Changes CI
21/10/25 Vertex, Inc. Announces CEO Changes CI
14/10/25 Vertex, Inc. Achieves Oracle Validated Integration for Delivering A Proven, Repeatable Integration for Oracle's ERP Solution CI
26/09/25 Stephens Initiates Vertex at Overweight With $30 Price Target MT
17/06/25 Piper Sandler Initiates Coverage on Vertex With Overweight Rating, $48 Price Target MT
22/04/25 BNP Paribas Exane Initiates Coverage on Vertex With Outperform Rating, $54 Price Target MT
28/02/25 Stifel Downgrades Vertex to Hold From Buy, Adjusts Price Target to $31 From $58 MT
28/02/25 Morgan Stanley Lowers Price Target on Vertex to $57 From $62, Keeps Overweight Rating MT
03/01/25 Raymond James Downgrades Vertex to Market Perform From Outperform MT
31/12/24 DA Davidson Initiates Vertex at Buy With $62 Price Target MT
13/11/24 Morgan Stanley Raises Price Target on Vertex to $62 From $50, Keeps Overweight Rating MT
04/11/24 Jefferies Upgrades Vertex to Buy, Price Target is $50 MT
23/07/24 Baird Initiates Coverage on Vertex With Outperform Rating, $43 Price Target MT
23/04/24 Citigroup Adjusts Price Target on Vertex to $32 From $34, Keeps Neutral Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+27.35%
+17.84%
+6.52%
+26.62%
+21.03%
+40.79%
+32.13%
+19.73%
+9.87%
+4.84%
Average +20.67%
Weighted average by Cap. +17.45%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
13.47USD
Average target price
17.15USD
Spread / Average Target
+27.35%
High Price Target
25.00USD
Spread / Highest target
+85.60%
Low Price Target
12.00USD
Spread / Lowest Target
-10.91%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Morgan Stanley
TD Cowen
Jefferies & Co.
Piper Sandler
Stephens Inc.
BNP Paribas Exane
Stifel Nicolaus
Raymond James
DA Davidson
Citigroup
BofA Securities
JMP Securities
Goldman Sachs
BMO Capital
Needham & Co.
Berenberg Bank
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
13.47USD
Average target price
17.15USD
Spread / Average Target
+27.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VERX Stock
  4. Consensus Vertex, Inc.